CHARLESTON, W.Va. -
June 2, 2026 -
PRLog -- PeptideMonitor, a new iOS app for people running peptide, GLP-1, and longevity protocols, is now available on the App Store. Founded by Tomas Sniukas, it goes beyond dose logging to answer the question every serious protocol user has:
is this working? The app runs statistical analysis on your biometric data, comparing your active phase against a 14-day baseline using the same methodology found in clinical research.
Most tracker apps stop at logging doses and sending reminders. PeptideMonitor fills the gap with statistical proof, not vibes — applying Welch's t-test, Cohen's d effect sizes, and baseline-versus-
active comparisons to your recovery, HRV, resting heart rate, and weight, then telling you with confidence levels whether your stack is producing real results.
Built for people running serious protocols — GLP-1s, peptides, longevity stacks, and hormone optimization — it's designed for anyone investing $200+ a month in compounds who wants evidence, not guesswork. The app does not sell compounds, provide medical advice, or issue prescriptions.
Core features include: - Statistical Insights: Active phase compared against a 14-day baseline — p-values, effect sizes, sample sizes — to detect real effects versus normal fluctuation.
- Wearable Integration: Connect Apple Health, WHOOP, or Oura to auto-pull HRV, recovery, resting heart rate, and weight.
- Anomaly Detection: Spikes, below-baseline streaks, and meaningful deviations surfaced as they happen.
- Compound Research: Every card includes PubMed counts, ClinicalTrials.gov data, receptor targets, and phase-of-research indicators.
- Lab Parsing: Upload bloodwork PDFs or DEXA scans, and the app extracts every marker automatically.
- Protocol Management: Build your stack, track doses, manage vials, and calculate reconstitutions.
PeptideMonitor starts with a 14-day free trial. After the trial, Pro is $14.99/month or $89.99/year (save 50%), cancellable anytime in Settings. Available now on iOS, requires iOS 15.1 or later.
About PeptideMonitor: PeptideMonitor is an iOS app for analyzing peptide, GLP-1, and longevity protocols, founded by Tomas Sniukas. It applies clinical-research statistical methods to biometric data from Apple Health, WHOOP, and Oura, telling users whether their protocol is working. The app does not sell compounds or provide medical advice. Available on the App Store following a 14-day free trial.
PeptideMonitor is for educational and research purposes only. It is not medical advice and does not provide prescriptions or diagnoses. Verify every calculation. Always consult a qualified healthcare professional before starting any compound protocol.Media Contact: Tomas Sniukas ·
info@peptidemonitor.app ·
https://peptidemonitor.app
Account Phone Number